Suppr超能文献

小儿胃肠道溃疡疾病的演变:急性外科干预是否相关?

Evolution of pediatric gastrointestinal ulcer disease: Is acute surgical intervention relevant?

机构信息

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, 55905, USA.

Department of General Surgery, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA.

出版信息

J Pediatr Surg. 2021 Oct;56(10):1870-1875. doi: 10.1016/j.jpedsurg.2021.02.010. Epub 2021 Feb 16.

Abstract

BACKGROUND

There is a lack of contemporary data about pediatric gastrointestinal ulcer disease. We hypothesized that ulcers found in immunosuppressed children were more likely to require surgical intervention.

METHODS

All children <21 years (n = 129) diagnosed with ulcers at a quaternary hospital from 1990 to 2019 were retrospectively reviewed. Clinical findings and pertinent information were collected.

RESULTS

Of 129 cases, 19 (14.7%) were immunosuppressed. Eight were post-transplant; four were diagnosed with post-transplant lymphoproliferative disease (PTLD).  Eight were associated with cancer. Three were both.  Three of 19 immunosuppressed and 28/110 immunocompetent patients were taking acid suppression therapy. Nine immunosuppressed patients required surgical intervention, including all PTLD cases, compared to 14 immunocompetent (47.3% vs 16.4%, p < 0.01). Five patients had duodenal perforation, two had multiple small bowel perforations, and two had uncontrolled bleeding. Of 9/19 immunosuppressed patients, surgical complications included bleeding (n = 7), sepsis (n = 2), ostomy reoperation/readmissions (n = 2), and death within 30 days (n = 2). Two/eighteen immunocompetent patients had bleeding complications.

CONCLUSION

Surgical treatment for ulcers remains relevant for pediatric patients. Immunosuppressed patients have more complications, longer hospital stays, and are more likely to need surgical intervention. Efforts should be made for ulcer prophylaxis with a low threshold to investigate epigastric pain in these complex patients.

LEVEL OF EVIDENCE

Prognosis Study Level III Evidence.

摘要

背景

目前缺乏有关儿科胃肠道溃疡疾病的当代数据。我们假设,在免疫抑制儿童中发现的溃疡更有可能需要手术干预。

方法

回顾性分析了 1990 年至 2019 年在一家四级医院诊断为溃疡的所有<21 岁的儿童(n=129)。收集了临床发现和相关信息。

结果

在 129 例病例中,有 19 例(14.7%)存在免疫抑制。其中 8 例为移植后,4 例为移植后淋巴组织增生性疾病(PTLD)。8 例与癌症相关。3 例同时存在。19 例免疫抑制患者中有 3 例和 110 例免疫功能正常的患者中有 28 例正在服用酸抑制治疗。9 例免疫抑制患者需要手术干预,包括所有 PTLD 病例,而免疫功能正常的患者中只有 14 例(47.3% vs 16.4%,p<0.01)。9 例免疫抑制患者中有 5 例出现十二指肠穿孔,2 例出现多处小肠穿孔,2 例出现无法控制的出血。在 9 例免疫抑制患者中,手术并发症包括出血(n=7)、败血症(n=2)、造口再手术/再入院(n=2)和 30 天内死亡(n=2)。在 18 例免疫功能正常的患者中,有 2 例发生出血并发症。

结论

手术治疗仍然适用于儿科患者的溃疡。免疫抑制患者并发症更多,住院时间更长,更有可能需要手术干预。应努力预防溃疡,对这些复杂患者出现上腹痛时应及早进行调查。

证据水平

预后研究 III 级证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验